TG Therapeutics (TGTX) stock spikes as Roche (RHHBY) fails in a Phase 3 trial for a high dose version of its multiple sclerosis therapy
https://seekingalpha.com/news/4428134-tg-therapeutics-stock-rises-roches-trial-fails
TG Therapeutics (TGTX) stock spikes as Roche (RHHBY) fails in a Phase 3 trial for a high dose version of its multiple sclerosis therapy
https://seekingalpha.com/news/4428134-tg-therapeutics-stock-rises-roches-trial-fails
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.